Books published by Elsevier - Health Sciences Division

Brydson''s Plastics Materials, Eighth Edition, provides a comprehensive overview of the commercially available plastics materials that bridge the gap between theory and practice. The book enables scientists to understand the commercial implications of their work and provides engineers with essential theory. Since the previous edition, many developments have taken place in plastics materials, such as the growth in the commercial use of sustainable bioplastics, so this book brings the user fully up-to-date with the latest materials, references, units, and figures that have all been thoroughly updated. The book remains the authoritiative resource for engineers, suppliers, researchers, materials scientists, and academics in the field of polymers, including current best practice, processing, and material selection information and health and safety guidance, along with discussions of sustainability and the commercial importance of various plastics and additives, including nanofillers and graphene as property modifiers. With a 50 year history as the principal reference in the field of plastics material, and fully updated by an expert team of polymer scientists and engineers, this book is essential reading for researchers and practitioners in this field.Presents a one-stop-shop for easily accessible information on plastics materials, now updated to include the latest biopolymers, high temperature engineering plastics, thermoplastic elastomers, and moreIncludes thoroughly revised and reorganised material as contributed by an expert team who make the book relevant to all plastics engineers, materials scientists, and students of polymersIncludes the latest guidance on health, safety, and sustainability, including materials safety data sheets, local regulations, and a discussion of recycling issues

This book provides a comprehensive overview of how use of micro- and nanotechnology (MNT) has allowed major new advance in vaccine development research, and the challenges that immunologists face in making further progress. MNT allows the creation of particles that exploit the inherent ability of the human immune system to recognize small particles such as viruses and toxins. In combination with minimal protective epitope design, this permits the creation of immunogenic particles that stimulate a response against the targeted pathogen. The finely tuned response of the human immune system to small particles makes it unsurprising that many of the lead adjuvants and vaccine delivery systems currently under investigation are based on nanoparticles.Provides a comprehensive and unparalleled overview of the role of micro- and nanotechnology in vaccine developmentAllows researchers to quickly familiarize themselves with the broad spectrum of vaccines and how micro- and nanotechnologies are applied to their developmentIncludes a combination of overview chapters setting out general principles, and focused content dealing with specific vaccines, making it useful to readers from a variety of disciplines